News|Articles|December 3, 2025

4 Psychiatry Headlines You Missed in November 2025

Fact checked by: Tim Smith

This month in review highlights November’s biggest psychiatry stories, including FDA moves, phase 4 findings, and new data on digital mental health tools.

November brought a mix of regulatory milestones, late-phase clinical insights, and evolving digital health trends across psychiatry. From the US Food & Drug Administration’s (FDA) first clearance of Deep Transcranial Magnetic Stimulation (Deep TMS) for adolescents with major depressive disorder (MDD) to a New Drug Application (NDA) filing that could introduce a novel ADHD mechanism of action, the month highlighted both therapeutic innovation and shifting treatment paradigms.